baber/WOPTO huggingface dataset:
Patent NZ-240759-A (NZ)
Title: A method of stabilising aqueous hydrolysable organosilane solutions by adding a water-soluble quaternary ammonium compound and a surfactant; solutions so stabilised
Inventor: AVERY RICHARD WILLIAM
IPC: D06M16/00
Filed: 1991-11-27
Abstract: A method of improving the stability and broadening the range of pH stability of an aqueous solution of from about 0.001 % to 5 % by weight of a water soluble organosilane containing hydrolyzable groups such as methyltrimethoxysilane, 3-(trimethoxysilyl)propyldimethyloctadecyl ammonium chloride and 3-(trimethoxysilyl)-propylmethyldi(decyl) ammonium chloride by the use of 0.05 % to 10 % by weight of a water soluble organic quaternary ammonium compound having at least one nitrogen-bonded hydrocarbon group of at least 8 carbon atoms and being free of silicon atoms, such as benzalkonium chloride, along with from about 0.5 % to 30 % by weight of at least one surfactant selected from the group consisting of nonionic, amphoteric sarcosine anionic, and cationic surfactants other than the water soluble quaternary ammonium compounds. The pH of the solution can be adjusted to from about 1 to about 13.5 with a suitable acid or base. The resulting stable aqueous solutions are useful for depositing the water soluble organosilane on a variety of substrates to, among other things, serve as coupling agents, waterproofing agents and to render substrates antimicrobial and algicidal depending upon the nature of the organosilane.
Patent NZ-245263-A (NZ)
Title: The use of 5,6-dihydro-dibenz[b,e]azepine-6,11-dione-11-oxime derivatives in medicaments
Inventor: WILD HANNO
IPC: A61K31/00
Filed: 1992-11-25
Abstract: The invention relates to 5,6-dihydrodibenz[b,e]azepine-6,11-dione-11-oximes of the formula I, a process for their preparation and their use as inhibitors of reverse transcriptase and in particular as retroviral agents. <IMAGE>
Patent NZ-248342-A (NZ)
Title: 9-[(substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines and pharmaceutical compositions
Inventor: SUM PHAIK-ENG
IPC: C07C/
Filed: 1993-08-06
Abstract: The invention provides compounds of the formula: <CHEM> wherein R, R<1> and W are defined in the specification. These compounds are useful as antibiotic agents.
Patent NZ-249899-A (NZ)
Title: Preparation of phenylisoserine, lactam precursors
Inventor: BOURZAT JEAN-DOMINIQUE
IPC: C07D205/08
Filed: 1993-03-08
Abstract: PCT No. PCT/FR93/00224 Sec. 371 Date Sep. 26, 1994 Sec. 102(e) Date Sep. 26, 1994 PCT Filed Mar. 8, 1993 PCT Pub. No. WO93/17997 PCT Pub. Date Sep. 16, 1993This invention relates to a method for preparing  beta -phenylisoserine and analogues thereof having general formula (I)    <IMAGE>  (I)  from an aromatic aldehyde and an  alpha -methylarylamine-S, and through a lactam of general formula (II) as described herein. The acids of general formula (I) (R=H) may be used to prepare taxane derivatives having remarkable antitumoral and antileukaemic activity.
Patent NZ-269575-A (NZ)
Title: 1-aminoalkyl(and azacycloalkylalkyl)-4-azacycloalkyl piperidine derivatives; pharmaceutical compositions
Inventor: MILLER SCOTT CARSON
IPC: A61K31/513
Filed: 1994-08-15
Abstract: Pharmaceutical compositions containing novel therapeutic heterocycles for use in diseases in which an NK2 receptor is implicated, processes for preparing and methods for using the same.
Patent NZ-281315-A (NZ)
Title: Sensor for the optical determination of ions
Inventor: ALDER ALEX
IPC: C09B11/28
Filed: 1995-03-13
Abstract: A composition comprising (a) a transparent support (b) which is coated on at least one side with a transparent coating which comprises (b1) a plasticizer-free, hydrophobic polymer having a glass transition temperature Tg of from -150 to 50 DEG  C., (b2) counterions in the form of lipophilic salts, (b3) an ionophore which forms a complex with the ion to be determined, and (b4) a compound of the formula I or II as fluorophore  in which R1 and R3, and R4 and R6 are C1-C30alkyl or C1-C30alkyl-CO-, and R2 and R5 are H or C1-C30alkyl, with the proviso that the total number of carbon atoms in the alkyl groups is at least 5, or a salt thereof with an inorganic or organic acid. The composition is highly suitable for the qualitative or quantitative optical determination of ions by fluorescence detection.
Patent NZ-332714-A (NZ)
Title: Conveyor with tipping cups, tipped by disengaging latch
Inventor: MADDEN IAN ROBERT
IPC: B65G47/40
Filed: 1995-08-23
Abstract: A support and discharge mechanism for a conveyer includes a support member 146 that is attached to a conveyor chain.  The support member supports a cup assembly 160.  The cup is pivotally attached to a pair of radius arms 153, 154 that are pivotally attached to the support member.  A latch assembly 171 is also attached to the cup assembly.  The latch assembly has a latching member that engages the support member.  An upward force on the latch assembly  causes the latch member to disengage from the support member allowing the cup to pivot downwardly and discharge a load supported on the cup.
Patent NZ-334768-A (NZ)
Title: Brushless DC motor, stator disc has flattened inverted conical cross section
Inventor: NOBLE ERNEST JOHN
IPC: H02K15/085
Filed: 1999-03-23
Abstract: A disk type stator 507 for a discoid rotary dynamoelectric machine (preferably a brush-less DC motor) includes a plurality of radially disposed groups of conductors 503 laid in slots 504 formed by dividers.  The slots are tapered in plan view, the slots getting narrower towards the center of the disk.  The slots are also tapered in cross section so that they get deeper towards the center (which is at the top of the drawing).  The conductor windings 503 extend radially within the slots, and a ferromagnetic material such as clock spring wound iron laminations 509 may be laid over the bottom surface of the slots. The rotor 501 with permanent magnets 502 is separated from the stator by axial gap 508.
Patent NZ-337753-A (NZ)
Title: Methods and means for gene silencing in transgenic plants using CMV35S or GST-II-27 promoter in a viral plant DNA construct wherein RNA transcript includes a targetting sequence capable of down-regulating expression
Inventor: BAULCOMBE DAVID CHARLES
IPC: C12N15/84
Filed: 1998-02-12
Abstract: DNA constructs ("amplicons") comprising a promoter operably linked to DNA which can be transcribed in a plant cell to an RNA transcript, which RNA transcript includes plant virus sequence (e.g. derived from potato virus X) which confers on the RNA transcript the ability to replicate in the cytoplasm of the plant cell. The constructs may lack portions of the viral genome not required for such replication (e.g. coat proteins) but preferably include targeting sequence which is capable of down-regulating (for instance gene silencing) expression of one or more target genes, which may be endogenous plant genes, transgenes, or pathogen genes. Also described are corresponding vectors, host cells, plants (particularly having modified and/or silenced genes or being pathogen resistant) and plant products, plus also methods of producing and using these materials.
Patent NZ-500016-A (NZ)
Title: Composition for the detection of electrophilic gases containing a lewis base, a dye, a solvent and a rheology modifier
Inventor: VERDICCHIO ROBERT J
IPC: G01M3/20
Filed: 1998-04-16
Abstract: The composition for the detection of an electrophilic gas comprises: a) a lewis base capable of electrophilic reaction with the gas; b) a dye molecule capable of visibly indicating a colour change on protonation or deprotonation; c) a solvent for the dye, the base and the gas and d) a rheology modifier capable of producing a non-newtonian gel of components (a) + (b) + (c) + (d) which is sufficiently translucent to permit visual detection of change of colour of (b) and of sufficient pseudoplasticity/thixotropy to provide adhesion to vertical and horizontal surfaces.
Patent NZ-501817-A (NZ)
Title: Reducing respiratory depression by a delta receptor agonist
Inventor: MCNUTT ROBERT W
IPC: A61K38/08
Filed: 1997-10-01
Abstract: A method of reducing, treating or preventing drug-mediated respiratory depression, muscle rigidity, or nausea/vomiting in an animal, incident to the administration to the animal of a mixed delta/mu opioid agonist or a respiratory depression-mediating drug, comprising administering to the animal receiving the drug an effective amount of a delta receptor agonist compound. The delta agonist compound is shown as the general formula. Wherein; Ar is a 5- or 6-member carbocyclic or heterocyclic aromatic ring with atoms selected from the group consisting of carbon, nitrogen, oxygen and sulfur, and having on a first carbon atom thereof a substituent Y and on a second ring carbon thereof a substituent R1, Z is selected from the group consisting of hydroxyl, and esters thereof; hydroxymethyl, and esters thereof; and amino, and carboxamides and sulfonamides thereof; G is carbon or nitrogen; R2 is hydrogen, halogen, or C1-4alkyl, C2-4alkenyl, C1-4alkynyl; R3, R4 and R5 may be the same or different, and are independently selected from hydrogen and methyl, and wherein at least one of R3, R4 or R5 is not hydrogen, subject to the proviso that the total number of methyl groups does not exceed two, or any two of R3, R4 and R5 together may form a bridge of 1 to 3 carbon atoms; R6 is selected from the group consisting of hydrogen; C1-6alkyl, C2-6alkenyl, C2-6alkynyl; C3-6cycloalkyl; arylalkyl having C5-10aryl and C1-6alkyl moieties; alkoxyalkyl having C1-4alkoxy and C1-4alkyl moieties; C2-4cyanoalkyl; C2-4hydroxyalkyl; aminocarbonylalkyl having a C1-4alkyl moiety; and R12COR13, where R12 is C1-4alkylene, and R13 is C1-4alkyl or C1-4alkoxy.
Patent NZ-502866-A (NZ)
Title: Substituted 2-pyrrolidinone activators of PKC
Inventor: KOZIKOWSKI ALAN P
IPC: C07D207/26
Filed: 1998-09-08
Abstract: A compound of formula I, wherein R' and R2 are each independently (C1-C15)alkyl, (C2-C15)alkenyl, (C2-C15)alkynyl, (C3-C8)cycloalkyl, (C3-C8)cycloalkyl(C1-C10)alkyl, (C3-C8)cycloalkyl(C1-C15)alkenyl, (C3-C8)cycloalkyl(C1-C15)alknyl, (C1-C15)alkoxy, (C1-C15)alkanoyl, (C1-C15)alknoyloxy, aryl, heteroaryl, aryl(C1-C6)alkyl, heteroaryl(C1-C6)alkyl, aryl(C2-C15)alkenyl, heteroaryl(C2-C15)alkenyl, aryl(C2-C15)alkynyl, heteroaryl(C2-C15)alkynyl, aryl(C1-C15)alkoxy, heteroaryl(C1-C15)alkoxy, aryl(C1-C15)alkanoyl, heteroaryl(C1-C15)alkanoyl, aryl(C1-C15)alkanoyloxy, or heteroaryl(C1-C15)alkanoyloxy; wherein any R' or R2 is optionally substituted with one or more substituents independently selected from halo, nitro, cyano, hydroxy, trifluoromethyl, trifluoromethoxy, (C1-C15)alkyl, (C2-C15)alkenyl, (C2-C15)alkynyl, (C3-C8)cycloalkyl, (C3-C8)cycloalkyl(C1-C15)alkyl, (C3-C8)cycloalkyl (C2-C15)alkenyl, (C3-C8)cycloalkyl(C2-C15)alkynyl, (C1-C15)alkoy, (C1-C15)alkanoyl, (C1-C15)alkanoyloxy, C(=O)ORa, C(=O)NRbRc, OC(=O)ORa, OC(=O)NRbRc, and NReRf; and wherein any aryl or heteroaryl of R1 or R2 is optionally substituted on a non-aromatic carbon by a divalent (C2-C7)alkylene chain to form a (C3-C8)spirocycloalkyl; each Ra is independently hydrogen or (C1-C6)alkyl; each Rb and Rc is independently, hydrogen or (C1-C10)alkyl; or Rb, and Rc together with the nitrogen to which they are attached are a 5-6 membered heterocyclic ring; and each Re and Rf is independently hydrogen, (C1-C10)alkyl, (C1-C10)alkanoyl, phenyl, benzyl, or phenethyl; or Re and Rf together with the nitrogen to which they are attached are a 5-6 membered heterocyclic ring; or a pharmaceutically acceptable salt thereof. The compounds find use in treating cancer.
Patent NZ-503788-A (NZ)
Title: 4-aminothiazole derivatives and their use as inhibitors of cyclin-dependent kinases
Inventor: DUVADIE ROHIT K
IPC: C07D277/42
Filed: 1998-10-27
Abstract: A compound of formula (I), wherein: R1 is an optionally substituted group selected from alkyl ; alkenyl; alkynyl; alkoxyl; alcohol; carbocyclic or heterocyclic, monocyclic or fused or nonfused polycyclic, cycloalkyl; carbocyclic or heterocyclic, monocyclic or fused or non-fused polycyclic, aryl; carbonyl; ether; alkylcarbonyl; alkylaryl; alkylcycloalkyl; alkylalkoxyl; arylalkoxyl; thioether; thiol; and sulfonyl; wherein when R1 is substituted, each substituent independently is a halogen; haloalkyl; alkyl; alkenyl; alkynyl; hydroxyl; alkoxyl; amino; nitro; thiol; thioether; imine; cyano; amido; phosphonato; phosphine; carboxyl; thiocarbonyl; sulfonyl; sulfonamide; ketone; aldehyde; ester; oxygen; carbocyclic or heterocyclic, monocyclic or fused or non-fused polycyclic, cycloalkyl; or carbocyclic or heterocyclic, monocyclic or fused or non-fused polycyclic, aryl. R2 is a carbocyclic or heterocyclic, monocyclic or fused or non-fused polycyclic, ring structure having a substituent at the position adjacent to the point of attachment, which ring structure is optionally further substituted, where each substituent of R2 independently is a halogen; haloalkyl; alkyl ; alkenyl; alkynyl ; hydroxyl; alkoxyl; amino; nitro; thiol; thioether; imine; cyano; amido; phosphonato; phosphine; carboxyl; thiocarbonyl; sulfonyl; sulfonamide; ketone; aldehyde; ester; oxygen; carbocyclic or heterocyclic, monocyclic or fused or non-fused polycyclic, cycloalkyl; or carbocyclic or heterocyclic, monocyclic or fused or nonfused polycyclic, aryl. With the proviso that R1 is not selected from the groups (II). Also described is a pharmaceutical composition comprising the compound of formula (I) together with a pharmaceutically acceptable carrier. The compounds of formula (I) are useful for the inhibition of CDK4 or a CDK4/cyclin complex.
Patent NZ-503884-A (NZ)
Title: Treatment of fungus in trees by injection of salicylic acid
Inventor: SPIERS ADRIAN
IPC: A01G7/06
Filed: 2000-04-10
Abstract: A method of treatment of tree or vines infected with a xylem invading pathogen, including the steps of: a)	Drilling a hole into the central region or heart wood of the stem, trunk, or branches of the tree or vine, and b)	Injecting an amount of a low concentration solution of salicylic acid or a salt thereof into the hole that is effective to prevent, limit, control or cure the infection of the tree or vine and substantially without a phytotoxic reaction.
Patent NZ-503940-A (NZ)
Title: Syringe pump including a sensor mechanism for sensing the barrel size of a syringe
Inventor: COBB ANTHONY RICHARD
IPC: H03M1/30
Filed: 2000-04-12
Abstract: A syringe pump includes means for mounting a syringe 3, means 7 for engaging and driving a plunger 6 of the syringe, and a sensor mechanism 20 for sensing the barrel size of the syringe.  Sensor mechanism 20 includes a contact member 22 displaceable into contact with the outer surface of the barrel.  A mask member 30 is coupled with contact member 22 and is movable in response to movement of the contact member, and a row of a plurality of optical sensing means are positioned to receive radiation transmitted by the mask member.  Mask member 30 includes a plurality of transmitting regions arranged in a row.  Each transmitting region has a different length.  The syringe pump includes means responsive to the outputs from the sensors to determine the size of the barrel from the combination of the length of the row of sensing means receiving radiation transmitted on one of the transmitting regions and the position of an edge of the transmitting region.
Patent NZ-505546-A (NZ)
Title: Fungicide mixtures based on amide compounds and morpholine or piperidine derivatives
Inventor: EICKEN KARL
IPC: A01N1/00
Filed: 1998-12-15
Abstract: A fungicidal composition with active ingredients as an amide compound and one or more compounds of a carboxaamide, a valinamide, 1-(2-cyano-2-methoxyiminoacetyl)-3-ethyl urea, (benalaxyl or orufacem or metalaxyl or furalaxyl or oxydixyl), combined in a synergistically effective amount.
Patent NZ-505967-A (NZ)
Title: Apparatus affixing a wheel-alignment sensor on a motor-vehicle wheel rim
Inventor: WARKOTSCH DIRK
IPC: G01B21/26
Filed: 1998-11-20
Abstract: Device for affixing the wheel-alignment sensor is mounted on a main body at a given reference direction to it. Three support arms are mounted on the main body and run substantially radially in a plane, which is perpendicular to the reference direction. Spacers are mounted on the support arms in transversely displaceable manner thereto. The spacer ends that will constitute a three-point support on a wheel rim are situated in a plane, which is perpendicular to the reference direction. Element(s) to affix the main body to the wheel rim are provided. At least one of the spacers (24, 54) is adjustable transversely to its mounting arm. In this manner the position of the spacers can be matched to different pitches of wheel affixing nuts
Patent NZ-507688-A (NZ)
Title: Sewing fabric sheets, typically having one smooth side and one fur-like side, by forming folded edge on first sheet and then sewing on edge abutting second sheet
Inventor: HAN CHANG JAE
IPC: A41D27/24
Filed: 2000-10-24
Abstract: An edge 12' is formed about one sheet 10', and an edge of a second sheet 19' is located parallel and abutting against the formed edge. A first seam 22' is sewn, sheets 10' and 19' are separated and a second seam 24' is sewn. This is stated to provide an aesthetically acceptable joint for wearing reversible garment such as leather.
Patent NZ-510130-A (NZ)
Title: Chicken anaemia viruses of low pathogenicity
Inventor: SCHRIER CARLA CHRISTINA
IPC: C12N7/00
Filed: 2001-02-23
Abstract: Purified naturally occurring antigenic strains of chicken anaemia virus (CAV), which are isolated from turkeys in the field, are described.  They have reduced virulence in chickens thereby marking them particularly suited for preparing a live vaccine for protecting poultry against disease conditions resulting from CAV infection.
Patent NZ-511669-A (NZ)
Title: Water treatment apparatus with primary carbon filter and secondary oxidation filter with strands of brass and copper
Inventor: CAMPBELL DOUGLAS RONALD PATON
IPC: B01D39/00
Filed: 2001-05-11
Abstract: A first filter (not shown but located in housing 20) has carbon or synthetic carbon as an absorption medium. A second filter (also not shown but located in housing 20) has an oxidation medium including strands of brass and copper in the flow path.
Patent NZ-514018-A (NZ)
Title: Electric milk bubbling machine
Inventor: YEH CHUAN-JANG
IPC: A47J43/07
Filed: 2001-09-06
Abstract: A hand-held dry cell powered milk stirrer to make the froth for cappuccino includes a motor 20 driving a whisk 42 on the end of shaft 40.  A dry cell casing 30 is mounted above the motor within a cylindrical outer casing 10 that houses the motor.  When the knob 34 projecting from the top 13 of the outer casing is held down against the bias of the spring 35, the contacts 32, 33 from the dry cells are contacted with the motor contacts to power the motor.
Patent NZ-523583-A (NZ)
Title: Highly concentrated stable meloxicam solutions
Inventor: DANECK KLAUS
IPC: A61K31/5415
Filed: 2001-06-19
Abstract: Aqueous cyclodextrin-free solution of meloxicam for administration by oral or parenteral route, containing a pharmacologically acceptable meloxicam salt of an organic or inorganic base and one or more suitable excipients, wherein the content of dissolved meloxicam salt is more than 10 mg/ml. Also disclosed is the use of such a solution for preparing a pharmaceutical composition for treating pain, inflammation, fever and respiratory complaints in large farm animals.
Patent NZ-527019-A (NZ)
Title: A cable reel
Inventor: FLEMING THOMAS WILLIAM
IPC: B65H75/40
Filed: 2001-12-19
Abstract: A hand-held cable reel (1) is provided comprising a central cable receiving core (2) mounted between a pair of disc-like end flanges (3) having through holes (4) for receiving cable which can then be anchored on the flange (3) by, for example, wrapping it round one of the handles (6) which are offset from the core (2) and each other to facilitate the winding and unwinding of cable.
Patent NZ-528032-A (NZ)
Title: A game of chance played using a WAP capable cellular phone
Inventor: MCIVOR GARY JOHN
IPC: H04M3/493
Filed: 2003-09-04
Abstract: A game controller controls a game of chance by the controller receiving telephone calls from telephones where the users of the telephones desire to play a game of chance. The controller then sends a message or messages to the telephones which cause images to display on screens of the telephones wherein the images offer the telephone users a chance to win rewards in the game of chance. he controller then receives signals from the users accepting or declining the offers, in the cases of acceptance the images moving or changing such that they play out as a depiction of a roll or rolls of the game after which the images indicate a win or loss as the case may be, in the case of wins allocating rewards to the accounts of the players or telephone and in the event of a loss allocating a debit to the account of the player or telephone.
Patent NZ-529474-A (NZ)
Title: High strength high gas barrier cellular cushioning product
Inventor: KANNANKERIL CHARLES
IPC: B31D5/00
Filed: 2003-11-12
Abstract: An inflatable cellular cushioning article 10 for use in packaging applications is described. As the cushioning article 10 is not inflated until needed by the user, it is more economical to transport compared with pre-inflated products. The article includes two sheets 12,14 sealed together in a pattern defining a series of inflatable chambers 16 with inflation ports 24. The sheet materials and bonding methods are specified so that the cushioning product can withstand higher internal pressures than traditional inflatable packaging without separating or otherwise failing under conditions of high temperature or reduced atmospheric pressure.
Patent NZ-531570-A (NZ)
Title: DNA sequences for human angiogenesis genes
Inventor: GAMBLE JENNIFER RUTH
IPC: C12Q1/02
Filed: 2002-09-19
Abstract: A nucleic acid molecule having the sequence of SEQ ID NO:1 and a polypeptide with the sequence of SEQ ID NO:115 are described. The nucleic acid and polypeptide play a role in diseases associated with angiogenesis. Modulators of expression or activity of the polypeptide and nucleic acids can be used in the manufacture of a medicament for the treatment of angiogenesis related disorders, such as cancer, rheumatoid arthritis, diabetic retinopathy, psoriasis, and atherosclerosis. Also described are antibodies, methods of diagnosis, methods for screening candidate pharmaceutical compounds and non-human transgenic animals.
Patent NZ-534812-A (NZ)
Title: Composition for oral or rectal administration based on lipid carrier materials
Inventor: HERSLOF BENGT
IPC: A61K47/44
Filed: 2003-02-14
Abstract: Disclosed herein is a solid pharmaceutical or food supplement tablet composition which has a melting point of 25 DEG C or higher, comprising a continuous lipid phase component comprising galactolipids, glyceride esters of fatty acids, optionally one or several of water and mono- to trivalent alcohol in an amount of up to 15% by weight of the composition, and one or more agents selected from pharmacologically active agent and food supplement agent. Also disclosed is a corresponding tablet or a suppository, processes for the production of the composition and the tablet or suppository, and a use of the tablet or suppository in the manufacture of a medicament for treating conditions amenable to preventive or therapeutic treatment by administration of the tablet or suppository.